臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tung hung su"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 61-110 / 193 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-03-09T01:47:37Z	Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; TUNG-HUNG SU; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:36Z	Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus	Chen H.-L.; Lee C.-N.; Chang C.-H.; Ni Y.-H.; Shyu M.-K.; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; Chen D.-S.; Chan K.A.; Chang M.-H.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Wu J.-F.; Hsu H.-Y.; Liu C.-J.; TUNG-HUNG SU; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study)
臺大學術典藏	2021-03-09T01:47:36Z	Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2021-03-09T01:47:35Z	Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial	Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:35Z	Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2021-03-09T01:47:35Z	Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:34Z	Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study	Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:34Z	Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study	TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:33Z	Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection	Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:33Z	Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan	Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; TUNG-HUNG SU; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:32Z	Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque	Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; TUNG-HUNG SU; Chen C.-L.; Liu C.-J.; Shih S.-C.
臺大學術典藏	2021-03-09T01:47:32Z	Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus	TUNG-HUNG SU; Liu C.-J.; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:32Z	Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients	TUNG-HUNG SU; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; Chen C.-L.; Kao J.-H.; the C-TEAM study group; the Taiwan Liver Diseases Consortium
臺大學術典藏	2021-03-09T01:47:31Z	Unmet Needs in Clinical and Basic Hepatitis B Virus Research	TUNG-HUNG SU; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:31Z	High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments	Nien H.-C.; Hsu S.-J.; TUNG-HUNG SU; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; Kao J.-H.; Yang W.-S.
臺大學術典藏	2021-03-09T01:47:31Z	letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D	Kao C.-N.; TUNG-HUNG SU; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:30Z	Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in?chronic hepatitis B patients	TUNG-HUNG SU; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:30Z	Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrast	TUNG-HUNG SU; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:30Z	Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up	Chen H.-Y.; TUNG-HUNG SU; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-03-09T01:47:29Z	Combination therapy for chronic hepatitis B: Current updates and perspectives	TUNG-HUNG SU; Liu C.-J.
臺大學術典藏	2021-03-09T01:47:28Z	The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4	Chan H.L.Y.; Chen C.J.; Omede O.; Al Qamish J.; Al Naamani K.; Bane A.; Tan S.S.; Simonova M.; Cardenas I.; Derbala M.; Akin O.; Phillips R.O.; Abdelmageed M.K.; Abdulla M.; Adda D.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Chen D.S.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukši? B.; Maaroufi A.; Malu A.O.; Mateva L.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Mustapha B.; Nersesov A.; Ngige E.; Njouom R.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; TUNG-HUNG SU; Sultan K.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Nde H.
臺大學術典藏	2021-03-09T01:47:28Z	Strategies to manage hepatitis C virus infection disease burden?�Volume 4	Chen D.S.; Hamoudi W.; Mustapha B.; Layden J.; Nersesov A.; Reic T.; Garcia V.; Rios C.; Mateva L.; Njoya O.; Al-Busafi S.A.; Abdelmageed M.K.; Abdulla M.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al ghazzawi I.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Fung J.; Gamkrelidze I.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Himatt S.M.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kaliaskarova K.S.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukši? B.; Maaroufi A.; Malu A.O.; Mitova R.; Mohamed R.; Morovi? M.; Murphy K.; Nde H.; Ngige E.; Njouom R.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Opare-Sem O.; Owusu-Ofori S.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Razavi-Shearer K.; Redae B.; Rinke de Wit T.; Robbins S.; Roberts L.R.; Sanad S.J.; Sharma M.; Simonova M.; TUNG-HUNG SU; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Vince A.; Wani H.U.; Wong V.W.S.; Workneh A.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Schmelzer J.D.
臺大學術典藏	2021-03-09T01:47:27Z	Historical epidemiology of hepatitis C virus in select countries?�volume 4	Maaroufi A.; Vince A.; Himatt S.M.; Mohamed R.; Fung J.; Opare-Sem O.; Workneh A.; Njouom R.; Al ghazzawi I.; Abdulla M.; Kaliaskarova K.S.; Owusu-Ofori S.; Abdelmageed M.K.; Adda D.; Akin O.; Al Baqali A.; Al Dweik N.; Al Ejji K.; Al Kaabi S.; Al Naamani K.; Al Qamish J.; Al Sadadi M.; Al Salman J.; AlBadri M.; Al-Busafi S.A.; Al-Romaihi H.E.; Ampofo W.; Antonov K.; Anyaike C.; Arome F.; Bane A.; Blach S.; Borodo M.M.; Brandon S.M.; Bright B.; Butt M.T.; Cardenas I.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen P.J.; Chien R.N.; Chuang W.L.; Cuellar D.; Derbala M.; Elbardiny A.A.; Estes C.; Farag E.; Gamkrelidze I.; Garcia V.; Genov J.; Ghandour Z.; Ghuloom M.; Gomez B.; Gunter J.; Habeeb J.; Hajelssedig O.; Hamoudi W.; Hrstic I.; Hu C.C.; Huang C.F.; Hui Y.T.; Jahis R.; Jelev D.; John A.K.; Kamel Y.; Kao J.H.; Khamis J.; Khattabi H.; Khoudri I.; Konysbekova A.; Kotzev I.; Lai M.S.; Lao W.C.; Layden J.; Lee M.H.; Lesi O.; Li M.; Lo A.; Loo C.K.; Lukši? B.; Malu A.O.; Mateva L.; Mitova R.; Morovi? M.; Murphy K.; Mustapha B.; Nde H.; Nersesov A.; Ngige E.; Njoya O.; Nonkovi? D.; Obekpa S.; Oguche S.; Okolo E.E.; Omede O.; Omuemu C.; Ondoa P.; Phillips R.O.; Prokopenko Y.N.; Razavi H.; Razavi-Shearer D.; Redae B.; Reic T.; Rinke de Wit T.; Rios C.; Robbins S.; Roberts L.R.; Sanad S.J.; Schmelzer J.D.; Sharma M.; Simonova M.; TUNG-HUNG SU; Sultan K.; Tan S.S.; Tchernev K.; Tsang O.T.Y.; Tsang S.; Tzeuton C.; Ugoeze S.; Uzochukwu B.; Vi R.; Wani H.U.; Wong V.W.S.; Yacoub R.; Yesmembetov K.I.; Youbi M.; Yuen M.F.; Razavi-Shearer K.
臺大學術典藏	2021-03-09T01:43:25Z	Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection	Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:25Z	Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma	Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:24Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:24Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients	Liu C.-H.; Liu C.-J.; Hong C.-M.; TUNG-HUNG SU; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-03-09T01:43:24Z	Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis	TUNG-HUNG SU; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:23Z	Hepatitis b virus–specific t cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation	Rivino L.; Le Bert N.; Gill U.S.; Kunasegaran K.; Cheng Y.; Tan D.Z.M.; Becht E.; Hansi N.K.; Foster G.R.; TUNG-HUNG SU; Tseng T.-C.; Lim S.G.; Kao J.-H.; Newell E.W.; Kennedy P.T.F.; Bertoletti A.
臺大學術典藏	2021-03-09T01:43:23Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:22Z	Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma	Kuo Y.-C.; Shih S.-C.; Yu L.-Y.; Wu M.-S.; TUNG-HUNG SU; Liu C.-J.; Hu K.-C.
臺大學術典藏	2021-03-09T01:43:22Z	Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy	TUNG-HUNG SU; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:22Z	HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?	TUNG-HUNG SU; Tseng T.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:21Z	Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy	TUNG-HUNG SU; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:21Z	Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection	Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:21Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:20Z	Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B	Papatheodoridis G.V.; Manolakopoulos S.; TUNG-HUNG SU; Siakavellas S.; Liu C.-J.; Kourikou A.; Yang H.-C.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:19Z	Profile and value of FIB-4 in patients with dual chronic hepatitis C and B	Liu C.-J.; Tseng T.-C.; Yang W.-T.; TUNG-HUNG SU; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:19Z	Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection	TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:19Z	Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma	Liao S.-H.; TUNG-HUNG SU; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; Chen C.-H.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:18Z	Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma	TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:18Z	Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study	Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; TUNG-HUNG SU; Liao W.-C.; Chen C.-L.; Liu C.-J.; Shih S.-C.
臺大學術典藏	2021-03-09T01:43:17Z	Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers	Chang K.-C.; Chang M.-H.; Lee C.-N.; Chang C.-H.; Wu J.-F.; Ni Y.-H.; Wen W.-H.; Shyu M.-K.; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; Liu C.-J.; Chen D.-S.; Lin L.-H.; Chen H.-L.; Hwa H.-L.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Hsu H.-Y.; Chiu Y.-C.; TUNG-HUNG SU; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)
臺大學術典藏	2021-03-09T01:43:17Z	letter to the Editor: Deliberations More Than a Cut-off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation	Jeng W.-J.; Hsu Y.-C.; TUNG-HUNG SU; Chen C.-H.
臺大學術典藏	2021-03-09T01:43:17Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; TUNG-HUNG SU; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis	Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:43:16Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	TUNG-HUNG SU; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.

顯示項目 61-110 / 193 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 50980655 線上人數 : 993 教育部委託研究計畫計畫執行:國立臺灣大學圖書館